<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2023-102-7-706-712</article-id><article-id custom-type="edn" pub-id-type="custom">mervqc</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-3275</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕТОДЫ ГИГИЕНИЧЕСКИХ ИССЛЕДОВАНИЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>METHODS OF HYGIENIC AND EXPERIMENTAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Подходы к определению чувствительности кампилобактерий к антимикробным препаратам для мониторинга распространения антибиотикоустойчивых штаммов</article-title><trans-title-group xml:lang="en"><trans-title>Approaches to the antimicrobial susceptibility testing of Campylobacter to monitor the spread of antibiotic-resistant strains</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4020-0894</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Косилова</surname><given-names>Ирина Сергеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Kosilova</surname><given-names>Irina S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Канд. биол. наук, науч. сотр. лаб. разработки питательных сред ФБУН «Государственный научный центр прикладной микробиологии и биотехнологии», 142279, Оболенск.</p><p>e-mail: kosilova.irina@gmail.com</p></bio><bio xml:lang="en"><p>MD, PhD, Researcher, Nutrient Medium Development Laboratory, State Research Center for Applied Microbiology and Biotechnology (SRCAMB) of the Federal Service for Supervision in Protection of the Rights of Consumer and Man Wellbeing, Obolensk, 142279, Russian Federation.</p><p>e-mail: kosilova.irina@gmail.com</p></bio><email xlink:type="simple">kosilova.irina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4785-6418</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Домотенко</surname><given-names>Любовь В.</given-names></name><name name-style="western" xml:lang="en"><surname>Domotenko</surname><given-names>Lyubov’ V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5961-9041</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полосенко</surname><given-names>Ольга В.</given-names></name><name name-style="western" xml:lang="en"><surname>Polosenko</surname><given-names>Ol’ga V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9955-7447</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трухина</surname><given-names>Галина М.</given-names></name><name name-style="western" xml:lang="en"><surname>Trukhina</surname><given-names>Galina M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУН «Государственный научный центр прикладной микробиологии и биотехнологии» (ГНЦ ПМБ) Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State Research Center for Applied Microbiology and Biotechnology (SRCAMB) of the Federal Service for Supervision in Protection of the Rights of Consumer and Man Wellbeing</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФБУН «Федеральный научный центр гигиены имени Ф.Ф. Эрисмана» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific Center of Hygiene named after F.F. Erisman of the Federal Service for Supervision in Protection of the Rights of Consumer and Man Wellbeing</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>31</day><month>08</month><year>2023</year></pub-date><volume>102</volume><issue>7</issue><fpage>706</fpage><lpage>712</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Косилова И.С., Домотенко Л.В., Полосенко О.В., Трухина Г.М., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Косилова И.С., Домотенко Л.В., Полосенко О.В., Трухина Г.М.</copyright-holder><copyright-holder xml:lang="en">Kosilova I.S., Domotenko L.V., Polosenko O.V., Trukhina G.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/3275">https://www.rjhas.ru/jour/article/view/3275</self-uri><abstract><sec><title>Введение</title><p>Введение. Кампилобактериоз является одной из самых распространённых диарейных инфекций во всём мире. Ситуация осложняется значительным ростом случаев болезни, вызванных возбудителем Campylobacter spp., устойчивым к антимикробным препаратам (АМП). Сдерживание болезни требует проведения мониторинга распространения резистентных штаммов кампилобактерий, выделяемых как от больных людей и животных, так и из пищевых продуктов и воды.</p><p>Цель исследования — оценить результаты тестирования чувствительности кампилобактерий к антимикробным препаратам по требованиям методологий EUCAST и CLSI с использованием отечественных питательных сред.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследовании использовали музейные штаммы C. jejuni, C. coli, C. fetus и C. lari. Культивирование кампилобактерий проводили на Campylobacter Agar Base (HiMedia), среде Престона лабораторного изготовления и железо-эритрит кровяном агаре (ГНЦ ПМБ, Оболенск). Чувствительность к АМП определяли тремя методами: диско-диффузионным, градиентной диффузии и микроразведений с использованием агара и бульона Мюллера–Хинтон двух фирм-производителей (BD BBL и ГНЦ ПМБ, Оболенск) в соответствии с требованиями стандартов EUCAST и CLSI.</p></sec><sec><title>Результаты</title><p>Результаты. Отечественные и импортные агар и бульон Мюллера–Хинтон позволили получить идентичные результаты чувствительности Campylobacter spp. к АМП. Все исследованные штаммы кампилобактерий отнесены к одной и той же категории чувствительности при тестировании всеми тремя методами в рамках одной методологии (EUCAST или CLSI). Из-за различий пограничных значений МПК и диаметров зон подавления роста в стандартах EUCAST и CLSI наблюдались некоторые отличия в интерпретации результатов.</p></sec><sec><title>Ограничения исследования</title><p>Ограничения исследования. В работе определена чувствительность восьми штаммов, относящихся к четырём видам Campylobacter, к трём антимикробным препаратам тремя методами в соответствии с методологией EUCAST и CLSI.</p></sec><sec><title>Заключение</title><p>Заключение. Полученные результаты подтверждают возможность использования комплекса отечественных питательных сред для культивирования и мониторинга ситуации с распространением устойчивых к АМП штаммов Campylobacter spp., что особенно актуально в связи с выполнением программы импортозамещения.</p><p>Соблюдение этических стандартов. В исследовании не использован биологический материал от людей и животных. Использованы только музейные штаммы микроорганизмов, поэтому не требуется представления заключения комитета по биомедицинской этике или иных документов.</p></sec><sec><title>Участие авторов</title><p>Участие авторов:Косилова И.С. — концепция и дизайн исследования, проведение экспериментов, статистическая обработка материала, написание текста;Домотенко Л.В. — концепция и дизайн исследования, сбор материала, статистическая обработка материала, написание текста;Полосенко О.В. — проведение экспериментов, статистическая обработка материала, написание текста;Трухина Г.М. — редактирование.Все соавторы — утверждение окончательного варианта статьи, ответственность за целостность всех частей статьи.</p></sec><sec><title>Конфликт интересов</title><p>Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p></sec><sec><title>Финансирование</title><p>Финансирование. Работа выполнена в рамках отраслевой программы Роспотребнадзора.</p></sec><sec><title>Поступила 29</title><p>Поступила 29.12.2022 / Принята к печати 07.06.2023 / Опубликована 30.08.2023</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Campylobacteriosis is one of the most common diarrhea-associated infections over the world. The situation is getting worse along with increasing cases of the disease caused by the Campylobacter spp. pathogen resistant to antimicrobials (AMPs). Preventing the disease requires monitoring the spread of resistant Campylobacter strains isolated from both sick people and animals, food, and water.</p><p>Aim of the study is to evaluate the results of the antimicrobial susceptibility testing of Campylobacter according to the requirements of the EUCAST and CLSI methodologies using Russia-made nutrient media.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Collected and freshly isolated strains of C. jejuni, C. coli, C. fetus and C. lari were used. Campylobacter cultures were subcultured on Campylobacter Agar Base (HiMedia), Preston laboratory-produced medium and iron-erythritol blood agar (Obolensk). Their sensitivity to AMPs was determined by three methods as ffollows: disc diffusion, gradient diffusion and microdilutions using Mueller-Hinton agar, and broth of two manufacturers (BD BBL and Obolensk) according to EUCAST and CLSI.</p></sec><sec><title>Results</title><p>Results. Using Russian-made and imported Mueller-Hinton agar and broth allowed obtaining identical results for AMPs susceptibility of Campylobacter spp. The campylobacter strains were attributed to the same susceptibility category by all three methods in frame of any methodology (EUCAST or CLSI) when interpreting results. Due to differences in cutoffs of MIC and inhibition zone diameters in the EUCAST and CLSI standards, there were some differences in the interpretation of the results.</p></sec><sec><title>Limitations</title><p>Limitations. Eight strains of four species Campylobacter were tested for their susceptibility to three antimicrobials by three methods according to EUCAST and CLSI methodology.</p></sec><sec><title>Conclusion</title><p>Conclusion. The results obtained confirm the possibility of applying a complex of domestic nutrient media for cultivating and monitoring the spread of antibiotic resistant strains of Campylobacter spp. This is especially important in view of implementing the import substitution program.</p><p>Compliance with ethical standards. The research did not use human or animal biological materials. Only collected strains of microorganisms were studied, and therefore the conclusion of the biomedical ethics committee or some other documents is not required.</p></sec><sec><title>Contribution</title><p>Contribution:Kosilova I.S. — concept and design of the research, carrying out experiments, statistical processing of material, writing the text; Domotenko L.V. — concept and design of the research, collecting material, statistical processing of material, writing of the text; Polosenko O.V. — conducting experiments, statistical processing of material, writing text;Trukhina G.M. — reviewing.All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.</p></sec><sec><title>Conflict of interest</title><p>Conflict of interest. The authors declare no conflict of interest.</p></sec><sec><title>Acknowledgement</title><p>Acknowledgement. The work was carried out within the Rospotrebnadzor industry program.</p></sec><sec><title>Received</title><p>Received: December 22, 2022 / Accepted: June 7, 2023 / Published: August 30, 2023</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>кампилобактерии</kwd><kwd>кампилобактериоз</kwd><kwd>Campylobacter spp.</kwd><kwd>питательные среды</kwd><kwd>определение чувствительности микроорганизмов к антимикробным препаратам</kwd><kwd>агар Мюллера–Хинтон</kwd><kwd>бульон Мюллер–Хинтон</kwd><kwd>железо-эритрит кровяной агар</kwd></kwd-group><kwd-group xml:lang="en"><kwd>campylobacteriosis</kwd><kwd>Campylobacter spp.</kwd><kwd>nutrient media</kwd><kwd>determination of AMPs microorganism sensitivity</kwd><kwd>Mueller-Hinton agar</kwd><kwd>Mueller-Hinton broth</kwd><kwd>iron-erythritol blood agar</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Saeid J., Mahdi E., Taradon L. The worldwide trend of Campylobacter spp., infection from duck-related isolates and associated phenotypic and genotypic antibiotic resistance, since 1985: identifying opportunities and challenges for prevention and control. Poult. Sci. 2021; 100(8): 101213. https://doi.org/10.1016/j.psj.2021.101213</mixed-citation><mixed-citation xml:lang="en">Saeid J., Mahdi E., Taradon L. The worldwide trend of Campylobacter spp., infection from duck-related isolates and associated phenotypic and genotypic antibiotic resistance, since 1985: identifying opportunities and challenges for prevention and control. Poult. Sci. 2021; 100(8): 101213. https://doi.org/10.1016/j.psj.2021.101213</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kreling V., Falcone F.H., Kehrenberg C., Hensel A. Campylobacter sp.: Pathogenicity factors and prevention methods-new molecular targets for innovative antivirulence drugs? Appl. Microbiol. Biotechol. 2020; 104(24): 10409–36. https://doi.org/10.1007/s00253-020-10974-5</mixed-citation><mixed-citation xml:lang="en">Kreling V., Falcone F.H., Kehrenberg C., Hensel A. Campylobacter sp.: Pathogenicity factors and prevention methods-new molecular targets for innovative antivirulence drugs? Appl. Microbiol. Biotechol. 2020; 104(24): 10409–36. https://doi.org/10.1007/s00253-020-10974-5</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Литусов Н.В. Кампилобактерии. Екатеринбург; 2012.</mixed-citation><mixed-citation xml:lang="en">Litusov N.V. Campylobacteria [Kampilobakterii]. Ekaterinburg; 2012. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Молочкова О.В., Ковалев О.Б., Новокшонов А.А., Новосад Е.В., Россина А.Л., Шамшева О.В. Клинико-эпидемиологическая характеристика кампилобактериоза у детей. Педиатрия. 2017; 96(6): 53–6. https://doi.org/10.24110/0031-403X-2017-96-6-53-56 https://elibrary.ru/ztpvsb</mixed-citation><mixed-citation xml:lang="en">Molochkova O.V., Kovalev O.B., Novokshonov A.A., Novosad E.V., Rossina A.L., Shamsheva O.V. Clinical epidemiological characteristics of campylobacteriosis in children. Pediatriya. 2017; 96(6): 53–6. https://doi.org/10.24110/0031-403X-2017-96-6-53-56 https://elibrary.ru/ztpvsb (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Clayton J.B., Danzeisen J.L., Johnson T.J., Trent A.M., Hayer S., Murphy T., et al. Characterization of Campylobacter jejuni, Campylobacter upsaliensis, and a novel Campylobacter sp. in a captive nonhuman primate zoological collection. J. Med. Primatol. 2019; 48(2): 114–22. https://doi.org/10.1111/jmp.12393</mixed-citation><mixed-citation xml:lang="en">Clayton J.B., Danzeisen J.L., Johnson T.J., Trent A.M., Hayer S., Murphy T., et al. Characterization of Campylobacter jejuni, Campylobacter upsaliensis, and a novel Campylobacter sp. in a captive nonhuman primate zoological collection. J. Med. Primatol. 2019; 48(2): 114–22. https://doi.org/10.1111/jmp.12393</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Elhadidy M., Ali M.M., El-Shibiny A., Miller W.G., Elkhatib W.F., Botteldoorn N., et al. Antimicrobial resistance patterns and molecular resistance markers of Campylobacter jejuni isolates from human diarrheal cases. PLoS One. 2020; 15(1): e0227833. https://doi.org/10.1371/journal.pone.0227833</mixed-citation><mixed-citation xml:lang="en">Elhadidy M., Ali M.M., El-Shibiny A., Miller W.G., Elkhatib W.F., Botteldoorn N., et al. Antimicrobial resistance patterns and molecular resistance markers of Campylobacter jejuni isolates from human diarrheal cases. PLoS One. 2020; 15(1): e0227833. https://doi.org/10.1371/journal.pone.0227833</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">John M.A. In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline &amp; other antimicrobial agents. Indian J. Med. Res. 2013; 137(1): 187–90.</mixed-citation><mixed-citation xml:lang="en">John M.A. In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline &amp; other antimicrobial agents. Indian J. Med. Res. 2013; 137(1): 187–90.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kinga W., Jacek O. Antimicrobial resistance mechanisms among Campylobacter. BioMed Res. Int. 2013; 2013: 340605. https://doi.org/10.1155/2013/340605</mixed-citation><mixed-citation xml:lang="en">Kinga W., Jacek O. Antimicrobial resistance mechanisms among Campylobacter. BioMed Res. Int. 2013; 2013: 340605. https://doi.org/10.1155/2013/340605</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mofatt C.R.M., Kennedy K.J., O’Neill B., Selvey L., Kirk M.D. Bacteraemia, antimicrobial susceptibility and treatment among Campylobacter-associated hospitalisations in the Australian Capital Territory: a review. BMC Infect. Dis. 2021; 21(1): 848. https://doi.org/10.1186/s12879-021-06558-x</mixed-citation><mixed-citation xml:lang="en">Mofatt C.R.M., Kennedy K.J., O’Neill B., Selvey L., Kirk M.D. Bacteraemia, antimicrobial susceptibility and treatment among Campylobacter-associated hospitalisations in the Australian Capital Territory: a review. BMC Infect. Dis. 2021; 21(1): 848. https://doi.org/10.1186/s12879-021-06558-x</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Pedersen S.K., Wagenaar J.A., Vigre H., Roer L., Mikoleit M., Aidara-Kane A., et al. Proficiency of WHO Global Foodborne Infections Network External Quality Assurance System Participants in Identification and Susceptibility Testing of Thermotolerant Campylobacter spp. from 2003 to 2012. J. Clin. Microbiol. 2018; 56(11): 1–9. https://doi.org/10.1128/JCM.01066-18</mixed-citation><mixed-citation xml:lang="en">Pedersen S.K., Wagenaar J.A., Vigre H., Roer L., Mikoleit M., Aidara-Kane A., et al. Proficiency of WHO Global Foodborne Infections Network External Quality Assurance System Participants in Identification and Susceptibility Testing of Thermotolerant Campylobacter spp. from 2003 to 2012. J. Clin. Microbiol. 2018; 56(11): 1–9. https://doi.org/10.1128/JCM.01066-18</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Janssen R., Krogfelt K.A., Cawthraw S.A., van Pelt W., Wagenaar J.A., Owen R.J. Host-pathogen interactions in campylobacter infections: the host perspective. Clin. Microbiol. Rev. 2008; 21(3): 505–18. https://doi.org/10.1128/cmr.00055-07</mixed-citation><mixed-citation xml:lang="en">Janssen R., Krogfelt K.A., Cawthraw S.A., van Pelt W., Wagenaar J.A., Owen R.J. Host-pathogen interactions in campylobacter infections: the host perspective. Clin. Microbiol. Rev. 2008; 21(3): 505–18. https://doi.org/10.1128/cmr.00055-07</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ефимочкина Н.Р., Пичугина Т.В., Стеценко В.В., Быкова И.Б., Маркова Ю.М., Короткевич Ю.В. и др. Оптимизация методов контроля пищевых продуктов на основе создания дифференциально-диагностических сред для выделения и культивирования бактерий рода Campylobacter. Вопросы питания. 2017; 86(5): 34–41. https://elibrary.ru/zwawgt</mixed-citation><mixed-citation xml:lang="en">Efimochkina N.R., Pichugina T.V., Stetsenko V.V., Bykova I.B., Markova Yu.M., Korotkevich Yu.V., et al. Optimization of food control methods based on the creation of differential diagnostic environments for the isolation and cultivation of bacteria of the genus Campylobacter. Voprosy pitaniya. 2017; 86(5): 34–41. https://elibrary.ru/zwawgt (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ефимочкина Н.Р., Короткевич Ю.В., Стеценко В.В., Пичугина Т.В., Быкова И.Б., Маркова Ю.М. и др. Антибиотикорезистентность штаммов Campylobacter jejuni, выделенных из пищевых продуктов. Вопросы питания. 2017; 86(1): 17–27. https://elibrary.ru/xwveof</mixed-citation><mixed-citation xml:lang="en">Efimochkina N.R., Korotkevich Yu.V., Stetsenko V.V., Pichugina T.V., Bykova I.B., Markova Yu.M., et al. Antibiotic resistance of Campylobacter Jejuni strains isolated from food. Voprosy pitaniya. 2017; 86(1): 17–27. https://elibrary.ru/xwveof (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Кремлева А.А., Скоморина Ю.А., Ахметова Л.Ш., Подольская Т.B., Шепелин А.П., Полосенко О.В. Сравнительный анализ питательных сред отечественных и зарубежных производителей для выделения кампилобактерий. Бактериология. 2021; 6(2): 32–7.</mixed-citation><mixed-citation xml:lang="en">Kremleva A.A., Skomorina Yu.A., Akhmetova L.Sh., Podol’skaya T.B., Shepelin A.P., Polosenko O.V. Comparative analysis of nutrient media of domestic and foreign manufacturers for the isolation of campylobacteria. Bakteriologiya. 2021; 6(2): 32–7. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Попова А.Ю., Дятлов И.А. Микробиологический контроль качества пищевой продукции. М.: Династия; 2020.</mixed-citation><mixed-citation xml:lang="en">Popova A.Yu., Dyatlov I.A. Microbiological Control of the Quality of Food Products [Mikrobiologicheskiy kontrol’ kachestva pishchevoy produktsii]. Moscow; 2020. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">EUCAST. European Committee for Antimicrobial Susceptibility Testing. Available at: https://www.eucast.org</mixed-citation><mixed-citation xml:lang="en">EUCAST. European Committee for Antimicrobial Susceptibility Testing. Available at: https://www.eucast.org</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Thirtieth Informational Supplement. CLSI document M100. USA; 2020. Available at: https://clsi.org/standards/products/microbiology/documents/m100/</mixed-citation><mixed-citation xml:lang="en">Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Thirtieth Informational Supplement. CLSI document M100. USA; 2020. Available at: https://clsi.org/standards/products/microbiology/documents/m100/</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">EUCAST. Breakpoint tables for interpretation of MICs and zone diameters Version 12.0. Available at: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_12.0_Breakpoint_Tables.pdf</mixed-citation><mixed-citation xml:lang="en">EUCAST. Breakpoint tables for interpretation of MICs and zone diameters Version 12.0. Available at: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_12.0_Breakpoint_Tables.pdf</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infreguently Isolated or Fastidious Bacteria; Third Informational Supplement. CLSI document M45. USA; 2015: 22–4. Available at: https://clsi.org/standards/products/microbiology/documents/m45/</mixed-citation><mixed-citation xml:lang="en">Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infreguently Isolated or Fastidious Bacteria; Third Informational Supplement. CLSI document M45. USA; 2015: 22–4. Available at: https://clsi.org/standards/products/microbiology/documents/m45/</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Домотенко Л.В., Миронов А.Ю., Косилова И.С., Шепелин А.П. Стандартность дисков с антимикробными препаратами различных производителей в свете импортозамещения. Клиническая лабораторная диагностика. 2022; 67(9): 550–6. https://doi.org/10.51620/0869-2084-2022-67-9-550-556 https://elibrary.ru/afrbws</mixed-citation><mixed-citation xml:lang="en">Domotenko L.V., Mironov A.Yu., Kosilova I.S., Shepelin A.P. Standardness of antimicrobial discs by various manufacturers in the light of import substitution. Klinicheskaya laboratornaya diagnostika. 2022; 67(9): 550–6. https://doi.org/10.51620/0869-2084-2022-67-9-550-556 https://elibrary.ru/afrbws (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sharifi S., Bakhshi B., Najar-peerayeh S. Significant contribution of the CmeABC Efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates. Annal. Clin. Microbiol. Antimicrob. 2021; 20(1): 36. https://doi.org/10.1186/s12941-021-00439-6</mixed-citation><mixed-citation xml:lang="en">Sharifi S., Bakhshi B., Najar-peerayeh S. Significant contribution of the CmeABC Efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates. Annal. Clin. Microbiol. Antimicrob. 2021; 20(1): 36. https://doi.org/10.1186/s12941-021-00439-6</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Rodrigues J.A., Cha W., Mosci R.E., Mukherjee S., Newton D.W., Lephart P., et al. Epidemiologic associations vary between tetracycline and fluoroquinolone resistant Campylobacter jejuni infections. Front. Public Health. 2021; 9: 672473. https://doi.org/10.3389/fpubh.2021.672473</mixed-citation><mixed-citation xml:lang="en">Rodrigues J.A., Cha W., Mosci R.E., Mukherjee S., Newton D.W., Lephart P., et al. Epidemiologic associations vary between tetracycline and fluoroquinolone resistant Campylobacter jejuni infections. Front. Public Health. 2021; 9: 672473. https://doi.org/10.3389/fpubh.2021.672473</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Szczepanska B., Andrzejewska M., Spica D., Klawe J.J. Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas. BMC Microbiol. 2017; 17(1): 80. https://doi.org/10.1186/s12866-017-0991-9</mixed-citation><mixed-citation xml:lang="en">Szczepanska B., Andrzejewska M., Spica D., Klawe J.J. Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas. BMC Microbiol. 2017; 17(1): 80. https://doi.org/10.1186/s12866-017-0991-9</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wozniak-Biel A., Bugla-Płoskonska G., Kielsznia A., Korzekwa K., Tobiasz A., Korzeniowska-Kowal A., et al. High prevalence of resistance to fluoroquinolones and tetracycline Campylobacter spp. isolated from poultry in Poland. Microb. Drug Res. 2018; 24(3): 314–22. https://doi.org/10.1089/mdr.2016.0249</mixed-citation><mixed-citation xml:lang="en">Wozniak-Biel A., Bugla-Płoskonska G., Kielsznia A., Korzekwa K., Tobiasz A., Korzeniowska-Kowal A., et al. High prevalence of resistance to fluoroquinolones and tetracycline Campylobacter spp. isolated from poultry in Poland. Microb. Drug Res. 2018; 24(3): 314–22. https://doi.org/10.1089/mdr.2016.0249</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Wagner J., Jabbusch M., Eisenblätter M., Hahn H., Wendt C., Ignatius R. Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. Antimicrob. Agents Chem. 2003; 47(7): 2358–61. https://doi.org/10.1128/AAC.47.7.2358-2361.2003</mixed-citation><mixed-citation xml:lang="en">Wagner J., Jabbusch M., Eisenblätter M., Hahn H., Wendt C., Ignatius R. Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. Antimicrob. Agents Chem. 2003; 47(7): 2358–61. https://doi.org/10.1128/AAC.47.7.2358-2361.2003</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
